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Summary 
We have examined the kinetics of changes that occur in the helper T cell subset during murine 
acquired immunodefidency  syndrome, which occurs after infection with the mix of viruses known 
as BM5. We find that there is expansion of the CD4 T cells by 2 wk, 50% of the CD4 T cells 
become large as the disease progresses, and the CD4 T cell population is increasingly comprised 
of cells with a memory/activated phenotype. These effects are apparent by 2 wk postinfection, 
and the change is nearly complete by 6-8 wk. The phenotypic shift is paralleled by the loss 
of the ability of the CD4 T  cells to proliferate  or to produce interleukin 2 (IL-2), II.-3, IL-4, 
and interferon ?  in response to stimulation with mitogens, superantigen, or anti-CD3. There 
is no obvious expansion or deletion of CD4 T  cells expressing particular V/3 genes,  as might 
be expected if a conventional superantigen were driving the changes. The results suggest, however, 
that the total CD4 population has been driven to anergy by some potent polyclonal stimulus 
directly associated with viral infection. 
I 
nfection of C57BL/6 mice with the LP-BM5 (BM5) mix- 
ture of retroviruses (1) causes a fatal immunodefidency  syn- 
drome whose similarity to human AIDS has prompted the 
disease to be called murine acquired immunodeficiency syn- 
drome (MAIDS) 1 (2).  The disease is characterized  by dra- 
matic splenomegaly and lymphadenopathy, by hypergam- 
maglobulinemia and by loss ofT cell and later B cell function 
(3, 4). During the late stages of the disease, mice may de- 
velop B cell lymphomas and are susceptible to opportunistic 
infections. The disease in B6 mice is invariably fatal. The virus 
responsible for MAIDS is a defective murine leukemia virus, 
termed BM5  a (5) or Du5H (6), which may or may not re- 
quire the presence of helper virus for disease induction (7). 
The CD4 T cell subset is dramatically altered during the 
course of MAIDS. As the disease progresses,  there is a loss 
of helper T cell response to mitogens, with both prolifera- 
tion and II.-2 production virtually disappearing by the time 
the disease is full-blown (3, 8). It has also been shown that 
CD4 T cells undergo a phenotypic change losing expression 
of both SM3G11 and SM6C10 (8). Paradoxically, as the syn- 
drome progresses and mice infected with BM5 become im- 
munodeficient and as CD4 T cell function begins to decline, 
1 Abbreviations used  in this paper:  MAIDS, murine acquired immunode- 
ficiency syndrome;  Pl,  propidium iodide; SAG, superantigen;  TX, 
thymectomy. 
there is a &amatic increase in size of peripheral lymphoid 
organs, including an increase in the total number of CD4 
T cells. Of particular interest is the fact that mice depleted 
either of T cells, or of only the CD4 subset of T cells, fail 
to develop MAIDS (2, 9). The CD4 dependence of the dis- 
ease suggests that CD4 T  cells play an important positive 
role in the disease process despite their apparent immuno- 
deficiency. 
The expression of distinct patterns of cell surface antigens 
has been useful in discriminating among different subsets of 
T cells and also in suggesting the way such subsets interact 
with other cells, with lymphokines, and with various com- 
ponents of the extracellular  matrix. For instance, like other 
resting T  cells, antigen-inexperienced naive T  cells express 
no IL-2R p55 (10), and they express low levels of CD44 (11, 
12), which binds to hyaluronate (13), LFA-3 (CDllot/CD54), 
which binds to CD2 (14), and VLA-~I integrins (15). Naive 
T ceils express the high molecular weight form of CD45R 
identified by antibody to  CD45RA  in humans (16) and 
CD45RB (17) in mice. Naive cells also express high levels 
of the lymph node homing receptor t-sdectin, identified by 
Ab to MEL-14 (18), and they are apparently short-lived in 
that they are depleted after adult thymectomy (TX) (19). In 
contrast,  resting,  long-lived memory cells  are  CD44  hish, 
LFA-3his  h, express CD45K0, but not CD45KA, or B, and 
are MEb14-  (11-1% Most memory cells are resting and ex- 
press little ID2R 1o55 and are retained for >40 wk after TX 
1589  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/92/06/1589/11  $2.00 
Volume 175  June 1992  1589-1599 (19). When stimulated, naive cells synthesize and secrete only 
II.-2, while memory cells can secrete small amounts of Ib3, 
II.-4,  IL-5,  and IFN-~/in  addition  to II.-2 (17-21). 
The phenotype of activated,  responding  CD4 T  cells is 
less clear, although they are invariably II.-2K p55 positive and 
often have lost CD45RB and MEL-14. Activated T cells often 
have increased expression of adhesion molecules such as CD44, 
LFA-3,  and CD2  (17-20).  The marker  SM3G11 (3Gll),  a 
ganglioside, is expressed on CD4 T  of naive phenotype and 
is less  frequently  expressed  on  CD4  T  cells,  which  have 
memory phenotype (22, 23). Cells expressing 3Gll are also 
lost after TX (19).  The SM6C10 (6C10) epitope, which is 
apparently expressed on Thy-1 molecules, appears to increase 
as CD4 T  cells  differentiate  (23). 
Early studies of the MAIDS suggested that expansion of 
both B and T cells during disease was broadly polyclonal (24, 
25), with oligoclonal populations of B cells developing late 
in disease in concordance with B cell lymphoma generation 
(4). However, recent studies from Hfigin et al. (26) have sug- 
gested  that  BM5  d may encode a  superantigen  (SAG)  that 
preferentially stimulates the proliferation of CD4 T cells with 
TCK having either V135 or VBll. They found that  two B 
cell lymphomas,  originally isolated from MAIDS animals, 
stimulated  the  proliferation  of normal  splenic V/35 +  and 
V/311 + CD4 T  cells.  The ability of two of the three lym- 
phomas to stimulate the response correlated with the expres- 
sion of the defective viral gag product and was partially blocked 
by mAbs directed to that  product. 
Here we report studies on the phenotypic and functional 
changes in CD4 T  cells that accompany the progression of 
MAIDS.  We find  that  the  CD4  T  cell population  shifts 
from one with a heterogeneous phenotype characteristic of 
a mixed population of cells of naive and memory phenotype, 
to a more homogeneous population with a phenotype that 
broadly shares characteristics of memory and activated cells. 
We also find that  the loss of CD4 function extends to the 
mitogen-induced production of IL3, Ib4, and IFN-3' in ad- 
dition to II.-2. We suggest that this phenotypic shift of CD4 
T cells is indicative of their differentiation to a state that could 
be best characterized as anergic. In addition, we have exam- 
ined the V/3 usage of the CD4 T  cells during MAIDS and 
find no evidence for any strong  selection of any particular 
V/3(s).  These results suggest that a broad polyclonal stimu- 
lation has driven the total CD4 population to an anergic state. 
Materials and Methods 
Mice and Viruses.  C57BL/6 (B6) mice were either obtained from 
The Jackson Laboratory (Bar Harbor, ME) or bred in our own fa- 
cility. LP-BM5 (BM5) viral stocks were obtained as cell free super- 
natants of chronically infected SC-1 cells (24). Mice between 6 and 
8 wk of age were injected intraperitoneally  with 0.5 ml of BM5 
viral stock. A minimum of three mice per group were analyzed 
individually and compared with age-matched, uninjected control 
B6 mice. 
AntibodiesandRecorabinantL2/raphokines.  Cell lines were main- 
tained for mAb production  as previously described (27) and were 
used for cell depletions. These mAbs were to: Thy-l.2 (F7D5 and 
HO  13.14),  CD8  (HO2.2),  CD4  (RL172.4),  class  II  (Ia  TM) 
(D3.137) (a gift of Dr.  Susan Tonkonogy, North Carolina State 
University, Raleigh, NC), and JllD. Ab used for FACS  |  analysis 
include anti-CD4 PE-labeled GK1.5 (PE-GK1.5) (Becton Dickinson 
& Co., Mountain View, CA), and a panel of antibodies to pheno- 
type CD4 cells including: anti-CD44  (Pgp-1) (28), anti-CD45RB 
(23G2) (a gift of Dr. Ellen Pure, The Rockefeller University, New 
York, NY) (29), and anti-r-selectin (MEL-14) (30). Cell lines were 
used to generate Ab for indirect immunofluoreseence with fluoresce- 
inated KG7/9/1 (FL-RG7, mouse anti-rat K). Other mAbs used 
for staining were to LFA-l(FD44.1), ICAM-1  (31), L-PAM (32), 
3Gll and 6C10 (22), Ib.2K (7D4), and Ab specific for TCR VB 
chains included VI3 3, (5.1, 5.2), 6, 7, (8.1-8.3), 9, 11 (Pharmingen, 
San Diego, CA). For lymphokine assays, the following antibodies 
were obtained as ascites from nude mice (33): 11Bll  (anti-IL-4), 
7D4 and PC61 (anti-IL.2R), TRFK4 and TKFK5 (anti-I1,5), and 
R46A2 and XMG1.2 (anti-IFN-~/). Lymphokines were obtained 
as follows: human rib2 from Cetus Corp. (Emeryville, CA), mu- 
fine rlFN-3, from Amgen Biologicals (Thousand Oaks, CA), rib4 
and rib5 from X63.AgS-653 line that was transfected with the 
routine eDNA for either I1..4 or for I1,5 (34), (a kind gift of Dr. 
Fritz  Melchers, Basel Institutes  for  Immunology,  Basel, Swit- 
zerland). 
Preparation  of  CeUs.  Whole spleen cells depleted oferythrocytes 
by hypotonic lysis were used for staining. For functional analysis, 
CD4  T  cells obtained  from  spleens of either  uninfected  or 
BMS-infected animals were used. CD4 T cells were purified by 
treatment  with anti-CD8,  anti-JllD, and anti-class II plus com- 
plement.  Antibody treatment  was carried out on ice for 30 min, 
followed by a combination  of rabbit and guinea pig complement 
at 37~  for 45 min as previously described (35). 
Preparation of APC.  Spleen cells from either  uninfected  or 
BM5-infected animals were depleted of T cells by treatment  with 
anti-CD4,  anti-CD8,  and two anti-Thy-1 antibodies followed by 
complement treatment as described above. The resulting cell popu- 
lation  was treated with 50/~g/ml of mitomycin  C. 
Culture Conditions.  Medium used for all cultures was RPMI 
1640 (Irvine Scientific, Santa Ana, CA) supplemented with 200 
/~g/ml penicillin, 200/~g/ml streptomycin, 4 mM t-glutamine,  10 
mM Hepes, 5 x  10  -s M 2-ME, and 7.5% FCS (HyClone Labora- 
tories, Logan, UT). To determine the ability of CD4 T to produce 
lymphokines, purified CD4 T cells were cultured  at 10~/ml with 
control APC at 5  x  10S/m1, and with 2 ~g/ml Con A or 10 
/~g/ml SEA (Toxin Technologies, Sarasota, FL), 10/~g/ml anti-CD3, 
and 5 ng/ml PMA in 2-ml cultures in 24-well plates, Culture su- 
pernatants were harvested after 36 h, and c~ methylmannoside was 
added to neutralize any residual Con A. Supernatants were stored 
at  -20~  before analyzing lymphokine concentration.  Prolifera- 
tion was determined by mixing 106/ml of CD4 T and 5  x  10S/ml 
APC in triplicate cultures. 'zsI-UDR was added for the last 18 h 
of a 72-h culture. 
Lymphokine Assays.  Bioassays  for Ib2, I1,3, and I1,4, and the 
analysis of the data have been previously described (27, 33, 35). 
Briefly, I1,2 and II,4 were assayed using the NK indicator line, 
which is responsive to Ib2 and Ib4. To assay II.,2 content of the 
supernatants,  I1,4 was inhibited by addition of 111311. In parallel 
cultures, 1I:2 was blocked by addition of two anti-Ib2R antibodies 
to assay for IL-4. 
IL-3 was assayed  using the 32Dc15 line, which does not respond 
to other lymphokines  under  our assay conditions. 
Ib5 and IFN-3, were assayed by ELISA as described previously 
(18). Briefly, 96-well plates (Nunc, Roskilde, Denmark) were coated 
with 1/~g/ml of TRFK.5 anti-Ib5 or R46A2 anti-IFN-'y  anti- 
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containing 1% BSA and 0.05% Tween-20 for I h at 37~  followed 
by the incubation of samples and standards for 1 h at room temper- 
ature.  The plates were washed  and  further  incubated  with bi- 
otinylated TRFK.4 for II.-5 or XMG1.2 for IFN-~/at room tem- 
perature  for another  1 h, and peroxidase-conjugated streptavidin 
was added for 1 h at room temperature. Substrate containing  100 
/zg/ml O-phenylenediamine dihydrochloride and 200/zg/ml urea 
hydrogen peroxide in citrate phosphate buffer was added to plates 
and incubated for 30 min at room temperature  in the dark,  after 
which the reaction was terminated by the addition of 25% sulfuric 
acid to a final concentration  of 10%. Plates were read at 492 nm 
using a Multiskan MCC/340 ELISA reader (Titertek, McLean, VA). 
IFNw and II:5 were quantitated in comparison to known standards. 
FACS  ~ Analysis.  Freshly derived splenocytes were resuspended 
in red blood call lysing medium (Sigma Chemical Co., St. Louis, 
MO), washed in BSS with 5% FCS, and the resultant cells were 
resuspended in PBS containing  5% FCS and 0.1% sodium azide. 
A 100-#1 aliquot containing  106 cells was used for staining. Cells 
were stained with appropriate antibodies on ice for 30 rain, washed, 
and counterstained with a secondary labeled antibody. All cells were 
stained with PE-conjugated anti-CD4.  Cells were either fixed with 
1% methanol-free formaldehyde in PBS or analyzed immediately 
on a FACScan  |  flow cytometer  (Becton Dickinson  & Co.). 
For propidium  iodide (PI) staining, cells were prepared as de- 
scribed above and stained with PE-conjugated anti-CD4.  PI was 
added to cells to a final concentration  of 5/~g/ml,  and PI-  and 
CD4 cells were analyzed  immediately.  Data  are  shown as dot 
plots of gated CD4 or as histograms  obtained using Consort 30 
software. 
Results 
In  our  preliminary  studies  it  was clear  that  significant 
changes in the CD4 population were already apparent within 
2 wk of inoculation with the BM5 virus mixture. Therefore, 
we have focused our studies on the CD4 T cells taken within 
the first few weeks of infection,  and we have analyzed the 
early kinetics of the changes in function and phenotype as 
a way to investigate  the mechanisms  leading  to immuno- 
deficiency. 
Kinetics  of Changes  in  CD4  Number and Function  during 
MAIDS.  We analyzed groups of three individual mice at 
1, 2, 4, 6, and 8 wk postinfection,  and evaluated the early 
changes in the number of CD4 T cells. We determined total 
white cell recovery and the proportion of cells expressing CD4 
as detected by staining with PE-labeled anti-CD4.  Results 
of this analysis  are shown in Fig.  1. 
The total number of CD4 T cells recovered per spleen rose 
steadily from 1 to 6 wk postinfection,  but leveled off after 
￿9  e  30"  .s. 
101 
2  4  6 
Week  of  infection 
Figure 1.  CD4 T cells increase 
during BM5  infection.  Spleno- 
cytes from three individual mice 
per time point were stained with 
PE-labeled  anti-CD4.  Based  on 
white cell  recovery  and FACS  | 
analysis, the number of CD4 + T 
cells per spleen was calculated and 
data  is  presented  as  geometric 
mean and SE. 
that time.  The ratio of CD4 T  cells in infected over unin- 
fected B6 mice at 8 wk postinfection ranged from 1.2 to 2.0, 
with a mean of 1.7 for four experiments. Thus, the popula- 
tion  of  CD4  T  cells  clearly  underwent  moderate,  but 
significant expansion.  To begin to assess the fraction of the 
T  cells involved in response at different times after inocula- 
tion of virus, we examined the size of individual CD4 T cells 
by examining  their forward vs. side scatter in FACS  |  anal- 
ysis, reasoning that cells must enlarge before they divide. A 
large forward scatter indicates a larger cell volume. An ex- 
ample of such an analysis  of fresh, unseparated splenic cells 
gated on CD4 cells that exclude PI (live cells) from mice in- 
fected 1, 2, and 8 wk previously with BM5 vs. control age- 
matched animals is shown in Fig. 2. Only 5% of CD4 cells 
in control mice (A) gave a forward scatter significantly higher 
than the majority of cells (to the right of the dotted line). 
In contrast, in this experiment >10% of CD4 cells had higher 
forward scatter at  1 wk (B), and by 2 wk (C),  18%  CD4 
T cells were larger.  By 8 wk, 50% of the CD4 T cells were 
larger than the bulk of control cells (D). These results indi- 
cate that an increasing  proportion ofCD4 T cells in the BM5- 
infected animal are apparently participating  in the response 
to virus, at least by undergoing enlargement. It is interesting 
that this larger cell size is not accompanied by the conversion 
of the same proportion of cells to an II~2R p55-positive state, 
as  shown below (see Fig.  4). 
CD4 T  Cells in MAIDS Do Not Show an Altered Distribu- 
tion of TCR  Vfl Expression.  If the proliferation of CD4 T 
cells were due to the action of a Vf-selective element or SAG 
encoded by the BM5 viral mixture, the Vfl usage of the CD4 
T  cells in infected mice should shift to reflect the selective 
outgrowth of CD4 T  cells using TCR with the responsive 
Vfl(s). In parallel,  TCR using other nonselected Vfls should 
progressively decrease. As the responding population expanded, 
the changes in representation  of Vfls should become more 
and more dramatic.  Therefore,  we analyzed the expression 
of a panel of Vfl chains by staining and fluorescent analysis 
(Tables  1 and 2). We examined mice at  1, 3, 8, and 11 wk 
after BM5 infection. Splenocytes from groups of two to three 
mice at each time point were pooled and compared with cells 
from control mice. Because activated T cells might be differen- 
tially damaged by some purification techniques, whole spleen 
cells were used. To detect each V/g we stained first with Ab 
to the individual V~ followed by fluoresceinated Ab specific 
for the first Ab. After washing, we counterstained with PE 
anti-CD4 and analyzed only CD4 + T  cells. Results of sev- 
eral experiments  are summarized  in Table 1. 
We saw no striking,  consistent preference in Vfl usage, 
although there was some variability in expression of Vfls from 
experiment to experiment.  Shown in Table 2 is a summary 
of the mean ratio of different V3s with standard errors (in- 
fected/control determined at 8 wk) from all four experiments 
performed at this time point.  There were no differences in 
V3 usage that would be strong enough to indicate a truly 
Vfl-selective effect. There were slight increases in the ratio 
in BM5 infected vs. control mice for V35 (mean  1.75)  and 
Vfl7 (mean 2.0). However, there were no significant  decreases 
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Figure 2.  CD4 T cells show in- 
crease in size after infection with 
BMS.  Splenocytes  from (.4) control, 
(B) 1 wk, (C), 2 wk, and (D) 8 wk 
postinfection  were stained with PE- 
labeled anti-CD4 and Pl. We gated 
on CD4 +, Pl- live cells and show 
forward vs. side scatter from FACS  | 
analysis. 
in other Vfls (ranging from 0.76 to 1.30). Since 50% of CD4 
T  are large at this time, indicating that they have responded 
in some fashion, it must be concluded that cells bearing many 
Vfls are represented in the compartment of responding cells. 
Phenotype of CD4 T Cells in MAIDS.  Since CD4 T cells 
at different stages of differentiation and with different histo- 
ries of antigen exposure show very different expression  of 
many functionally rdevant cell surface markers (reviewed in 
Table  1.  Vff Usage in MAIDS Animals 
Percent CD4  with each VB 
Exp.  1  Exp.  2  Exp.  3  Exp.  4 
Control  Week 1  Control  Week 3  Week  11  Control  Week 8  Control  Week 8 
V~3  1.5  5.7  ND  ND  ND  4.2  5.5  2.8  4.9 
VB5.1,  5.2  2.6  4.2  2.7  6.3  3.8  2.2  3.3  3.7  6.6 
Vfl6  6.6  8.3  7.2  7.6  3.2  6.8  5.2  10.9  14.7 
V/~7  0.5  3.5  ND  ND  ND  1.7  1.8  2.3  5.8 
VB8.1,  8.2  7.2  8.7  16.2  14.2  11.4  10.3  10.8  10.3  10.3 
V~9  ND  4.3  ND  ND  ND  2.3  3.0  4.5  4.5 
V~11  5.8  4.4  4.4  5.3  3.1  4.8  3.4  9.4  6.0 
106 Splenocytes from control or infected animals at different weeks postinfection were double stained with PE-labeled anti-CD4 and VB-specific  an- 
tibodies. The percentage of V~-positive cells among CD4 cells was calculated based on FACS  |  analysis. 
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Spleens at 8 wk 
V/~-specific CD4 cells  BM5/control ratio 
VB3  1.30  +_  0.28 
VB5.1,  5.2  1.75  +  0.35 
V136  0.84  _+  0.33 
V~7  2.00  +_  0.63 
V/38.1,  8.2  1.05  _+  0.25 
V/39  0.94  _+  0.16 
VBll  0.76  _+  0.16 
Same as Table 1, except ratio of VB + CD4 cells of infected  over con- 
trol animals is shown as mean  +  SE. 
reference 19), it seemed likely that examination of the pheno- 
type of CD4 T cells in MAIDS animals would be informa- 
tive. An example of expression  of such a panel of markers 
by CD4 T cells in 6-wk BM5 infected (solid line) versus con- 
trol mice (dotted line) is shown in Fig. 3. Fig. 4 shows results 
with additional markers from a separate experiment at 8 wk 
postinfection. Both are representative of profiles seen in more 
than three experiments. The histograms reflect the staining 
intensities among the gated CD4 + population. CD4 T cells 
from normal animals were heterogeneous with respect to ex- 
pression of CD44, CD45RB, and the L-sdectin, MEI.-14 (Fig. 
3, left, middle, and right, respectively). Routinely, a majority 
of the  peripheral  CD4  T  cells  (60-80%),  shown  with 
dotted lines, had a naive phenotype (CD44  l~  MEbl4hig  h, 
CD45RBhlg h,  3Gll +)  rather  than  a  memory phenotype 
(CD44his  h, MEI.-14-, CD45RB  l~  3Gll-) (Figs. 3 and 4). 
Most resting T cells (both naive and memory) also express 
moderate levels of LFA-1 and 6C10, and low levels of L-PAM 
and ICAM-1, and they are almost all II.-2R negative (Fig. 4). 
In MAIDS animals, the majority of ceils express a pheno- 
type similar to that of memory cells or of activated T cells. 
The majority of T cells from BM5-infected animals became 
CD44 high, CD45RB  l~  and Mel-14-  (Fig. 3), a phenotype 
that characterizes both memory (19) and many activated CD4 
T cell populations. In addition, the MAIDS CD4 T cells ex- 
pressed  higher levels of LFA-1 and  ICAM-1  than  either 
memory or naive cells (Fig. 4). Their expression of L-PAM 
and IG2R was also slightly higher than that of resting cells. 
Although many cells appeared  to be activated  on the basis 
of forward scatter, the increase in IL-2R expression was quite 
slight in BM5-infected animals, and was considerably below 
the levels  expressed on activated Con A blasts or in vitro gener- 
ated effectors (not shown), which express very high levels 
of IG2R p55. As indicated previously (8), CD4 T  cells in 
BMS-infected animals express little 3Gll or 6C10, a pheno- 
type largely associated with a population of apparently non- 
functional CD4 cells (23). 
To better understand these phenotypic shifts, we have ana- 
lyzed the kinetics of the changes in expression of CD44, 
CD45RB, and MEb14. In Fig. 5, the marker-positive BM5 
cells as a percent of positive control cells has been determined 
for three individual animals per group at 1, 2, 4, 6,  and 8 
wk after infection. The mean percent of CD4 cells positive 
for each marker in individual infected mice versus the average 
in control mice with standard error of that mean is shown. 
This shift in expression  of CD44,  CD45RB, and MEL-14 
after BM5 infection phenotype was progressive, but was al- 
ready clearly detectable by 2 wk indicating a rapid change. 
Thus, the CD4 T  cells in BMS-infected  animals almost all 
have a unique phenotype that is significantly different from 
other well-characterized  subsets  of CD4 T  cells. 
Proliferative Response of CD4 T Cells during MAIDS.  We 
examined the proliferation of CD4 T cells from control mice 
and from mice infected with BM5 8 wk previously in re- 
sponse to a variety of stimulants. The results,  presented in 
Fig.  6 a, compare the responses of two individual control 
and BMS-infected animals. CD4 T cells from control mice 
proliferated vigorously to Con A and to anti-CD3, and gave 
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Figure 3.  Phenotypic  changes of CD4 ceils in MAIDS. Splenocytes from uninfected (dotted line) or animals 6 wk postinfection (solid line) were double 
stained with PE-labeled anti-CD4 and Ab to various cell surface markers. CD4 + cells were selected for analysis of their marker e~pression and results 
are shown as histograms.  A  minimum of three mice were used per experiment.  Results  are representative  of least three separate experiments. 
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Figure 4.  Surface phenotype of the CD4 T cells in BM5 infection.  Splenocytes from control mice (dotted line) or from mice 6-8 wk postinfection 
(solid line) were double  stained with PE-labeled anti-CD4 and Ab to cell surface markers for FACS  |  analysis as shown.  CD4 + cells were selected for 
analysis of their marker  expression and results  are shown as histograms. 
modest response to SEA. The addition of PMA somewhat 
improved the responses to TCR-directed reagents. Regard- 
less of the stimulant, BM5 CD4 T cells proliferated poorly. 
Since the MAIDS CD4 T cells had slightly elevated levels 
of IL-2R (Fig. 5), we also tested whether addition of II-2 
would reconstitute the proliferation of the CD4 T cells. The 
presence of 20 U/ml exogenous IL-2, a dose that in our hand 
supports maximum expansion of CD4 T cells, and ma,~'num 
proliferation  of activated CD4 T cells (33), had very little 
effect on the proliferation ofCD4 T cells from BM5-infected 
animals stimulated by Con A or Con A plus PMA (Fig. 6 
b). II-2 also had little effect alone or with SEA (not shown). 
Kinetics of Changes in Lymphokine Secretion by CD4 T Cells 
during MAIDS.  To confirm the loss ofCD4 T cell function 
and to further investigate the extent of the immunodeficiency 
among CD4 T cells after BM5 infection, CD4 T cells were 
purified from the spleens of the individual mice analyzed in 
Fig. 5 and mixed with APC from control animals. Cultures 
of cells from individual  spleens were stimulated with Con 
A and PMA, and supernatants harvested 36 h later. The titers 
of IL-2, IL-3, Ib4, IL-5, and IFN-y were determined in each 
supernatant. The mean values with standard errors from three 
individual mice are shown in Fig. 7. By 2 wk postinfection, 
mitogen-stimulated IL-2 production by the CD4  cells of 
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Figure 5.  Kinetics  of phenotypic changes in CD4 cells during BM5 infection.  Splenocytes from three individual  mice were double stained with 
PE-labeled anti-CD4 and antibodies  as shown.  The marker-positive cells as a percent  of control CD4 cells were set as 100%, and the changes in this 
percentage  after infection  is shown as mean  _+  SE of results from individual  mice. 
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Figure 6.  Failure  of MAIDS T cells to proliferate. (a) Proliferative  re- 
sponse of CD4 T cells to different  stimuli  in MAIDS. CD4 T-enriched 
cells from  groups of two individual  mice  8 wk after  infection  were  plated 
at 105, with 5 ￿  104 control APC, and stimulated  with SEA, c~CD3 + 
PMA, ~CD3, Con A + PMA, or Con A for 72 h, and ceUs were pulsed 
with ~2sI-UDR for the last 18 h. Extent of cell proliferation  is expressed 
as cpm per culture. Mean and SEs of triplicate cultures are shown. (b) 
Failure of Ih-2 addition  to reverse MAIDS immunodeficiency:  Same  as a, 
except rlL-2 was added at 20 U/ml to the cultures, wherever indicated. 
MAIDS animals was already significantly reduced to "~50% 
of control levels. By 6-8 wk postinfection, Ib2 production 
by CD4 T  cells from MAIDS mice was barely detectable. 
IL-4 and IL-3 production was also lost with time, but the 
kinetics of these changes were somewhat delayed with a two- 
fold reduction obvious only at 4-6 wk. I1-5 production was 
too low to be reproducibly detected in controls and is there- 
fore not shown, but little or no IL-5 production was seen 
at any time point. IFN-7 production appeared somewhat more 
resistant to the disease,  and significant decreases in IFN-7 
were not detected until 6-8 wk. The levels of IFN-% how- 
ever, were extremely low and quite variable between animals. 
Moreover, IFN-7 may be made by APC and possibly by the 
few contaminating CD8 T  cells. The kinetics of changes, 
in mitogen-stimulated lymphokine production after viral in- 
fection, especially of IL-2, which is the major lymphokine 
produced by CD4 T cells directly derived from animals, thus 
appears quite similar to those changes in cell surface marker 
expression. 
Since one report had suggested that II.-5 and Ib4 produc- 
tion was not lost in BMS-infected animals (36),  we further 
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Figure 7.  Kinetics  of changes in lymphokine  secretion  by CD4 T cells 
in MAIDS. 106 CD4 T-enriched  cells from  groups of three individual  mice 
at different  times  after  infection  were incubated for 36 h with Con A + 
PMA and with 5 ￿  105 control APC. Secreted lymphokines  were ana- 
lyzed by bioassays  for IL-2, IL-3, and II~4, and or by ELISAs  for IFN-7 
and Ib5. Data  is shown  as mean _+ SE for results  from  individual  animals. 
No IL-5 was detected. 
examined the I1.-4 production of infected animals to a variety 
of stimulants, and results are presented in Fig. 8. As expected, 
Ib2 production (Fig.  8 a) was completely absent by 8 wk 
postinfection regardless of whether Con A, anti-CD3 with 
or without PMA, or SEA was used to stimulate the cells. 
Similarly, II.-4 production was dramatically reduced and low 
IL-4 production was independent of the stimulant (Fig. 8 b). 
The low levels of IFN-3' produced by control cells was ab- 
sent in the BM5-infected mice and levels of 1I.-3 were reduced 
with similar effects seen regardless  of the mode of stimula- 
tion (not shown). No II:5 production was detected in any case. 
Discussion 
This analysis of the changes in CD4 T cells assodated with 
MAIDS, induced by BM5 retroviral infection, suggests that 
the initial resting immunocompetent CD4 population is quite 
rapidly replaced by a polyclonal population of CD4 T  cells 
that might best be described as anergic.  The CD4 popula- 
tion, which comes to predominate, largdy has a memory or 
activated phenotype as shown here, but responds poorly to 
mitogenic stimuli such as Con A, anti-CD3, or SEA. This 
anergy includes a loss of the ability to proliferate or to pro- 
duce Ib3,  IFN-%  and IL-4, as well as Ib2. 
How does this change in the overall population occur? There 
are several possibilities. First, the bulk of the naive cells could 
be induced to proliferate in a limited fashion and then be- 
come anergic. Alternatively, a smaller population of memory 
or naive cells could be stimulated to proliferate more exten- 
sively and their progeny could become the predominant popu- 
lation. Recently a number of studies have indicated that cer- 
tain bacteria, especially  of the Staphylococci and Streptococci a 
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Figure 8.  Lymphokine  secretion by CD4 T cells to different stimuli 
in MAIDS. 106 CD4 T-enriched cells from groups of two individual mice 
8 wk postinfection were incubated for 36 h with SEA, otCD3 + PMA, 
otCD3, Con A  +  PMA, or Con A, and with 5  x  10  s control APC. 
Secreted iymphokines (Ib2 and Ib4) were analyzed  by bioassays, and the 
amounts of each recovered  in the supernatants of each culture are shown. 
I1,3 and IFN-3, production were also suppressed (not shown), and no I1,5 
production was detected in any sample (not shown). 
families, and mouse mammary tumor viruses  (reviewed in 
references 37 and 38), each encode so-called SAG with similar 
properties. These SAG are V/3 selective,  stimulate strong 
proliferative responses and lymphokine  production by T cells 
in vitro, and induce initial proliferation followed by donal 
deletion and anergy when introduced in vivo (39, 40). The 
reasons that SAG are so effective at inducing a state of anergy 
are unclear. Recently it has been suggested that the BM5 virus 
may synthesize such a SAG with specificity for V35 and 
V/311 (26). 
The results in this study are more compatible with a large 
polyclonal response than with either a small or V•  selective 
response. First, the increase in CD4 T cell numbers (Fig. 1) 
and changes in phenotype (Figs. 2-4) and function (Figs. 5-8) 
can already be detected by 2-4 wk postinfection, and the 
changes plateau by 6-8 wk, indicating that even by 2-4 wk 
a majority of the CD4 T cell population has been affected. 
Even if a small fraction of virus-specific T cells or virally in- 
fected T cells were proliferating rapidly enough to come to 
represent a major proportion of the CD4 population, there 
is no a priori mason that the nonresponding  population should 
change phenotype and/or lose function. A broadly polyclonal 
response is also suggested by the lack of significant changes 
in the spectrum of VB TCR utilized by the CD4 T  cells 
in MAIDS vs. control animals  (Tables 1 and 2).  If only a 
small number ofCD4 T cells expressing  just a few VBs were 
responsible for the net increase in CD4 T cells, there should 
be a considerably more dramatic shift of V3 usage. This would 
be particularly obvious by 6-8-wk, when the total CD4 popu- 
lation has roughly doubled in number (Fig. 1), when "~50% 
of cells show increased forward scatter  (Fig. 2), and when 
the  phenotypic and  functional changes suggest  that  the 
majority of CD4 T  cells have become anergic (Figs. 3, 6, 
and 8). CD4 cells expressing VBs that selectively responded 
should show a dramatic increase in proportion, while those 
that had not participated in response should show a substan- 
tial reduction. No consistent changes in ratio of that magni- 
tude were detectable either at 1, 3, 8, or 11 wk of infection, 
and the changes in VB ratio at 8 wk were very modest with 
no V/8 showing more than a twofold increase or decrease 
(Table 2). Especially surprising, in light of the results from 
Morse's laboratory, was the fact that V35- and V311-positive 
cells, which are those that have been reported to selectively 
respond to a B cell lymphoma from BM5-infected mice (26), 
were neither selectively expanded nor deleted. This suggests 
that the conditions that lead to a V3 selective expansion in 
vitro are not present in vivo. It should be noted that although 
these results argue against a conventional V/gselective SAG 
model, they do not rule out the possibility that a viral com- 
ponent or product could have broader mitogen activity that 
is not detectably VB selective  but that causes a response similar 
to known SAGs. 
A surprisingly dramatic shift in phenotype of the majority 
of CD4 T  cells takes place after infection with BM5. The 
CD4 T cells in normal uninfected B6 animals include both 
naive and memory T cells. In young, healthy animals cells 
of naive phenotype usually predominate (60-80%).  These 
cells are included in a population with the following charac- 
teristics inferred both from cell separation  studies and from 
studies with adult thymectomized mice (reviewed in refer- 
ence 19). Naive cells are small, resting, relatively short-lived 
cells without IL-2R, they express moderate levels of LFA-1, 
low levels of CD44 (Pgp-1),  ICAM-1, L-PAM, and 6C10, 
and high levels of CD45RB, 3Gll, and the t-selectin MEb 
14. In contrast, resting, long-lived memory cells, which make 
up the other predominant component of peripheral CD4 cells, 
display a very different phenotype of high CD44 expression 
and low expression of CD45RB and MEL,14 and 3Gll. How- 
ever, like the naive cells, memory T cells express moderate 
levels of LFA-1 and low levels of ICAM and DPAM, and are 
II.-2R. negative. Activated or effector cells, which are repre- 
sented in very tow numbers in the peripheral CD4 T  cells 
from healthy mice (<5%) can be induced by polyclonal stim- 
ulation. Such population often express memory levels of CD44, 
CD45RB, and MED14 (18, 19), and display enhanced levels 
of LFA-1 and ICAM-1, and high levels of ID2R. 
The cells in MAIDS animals progress within 6 wk to a 
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and activated cells. Most of the CD4 T cells in BM5-infected 
animals expressed increased levels of CD44, uniformly low 
levels of CD45RB and ME1:14 (Fig. 3), and a majority of 
cells expressed no 3Gll or 6C10 (Fig. 4; and see reference 
8). There was a dramatic increase in the expression of LFA-1 
and ICAM-1 and a lower but significant increase in expres- 
sion of 1:PAM. Only a small population of cells expressed 
the p55 I1:2R, and they did so at low levels. This phenotype 
is  unusual,  including the  expression  of many activation 
markers, but without the expression of the high levels of I1:2R 
normally found on activated T cells. The lack of expression 
of  both 3Gll and 6C10 has been previously reported in MAIDS 
and has been associated with the CD4 population with little 
function in previous studies (8,  22, 23). 
This unique cell surface phenotype was associated with 
a concomitant and severe loss of responsiveness. The CD4 
T  cells no longer proliferated to mitogenic stimulation (3; 
and Fig. 6).  This dramatic loss of proliferative  response is 
seen with Con A, anti-CD3, and SEA,  and is not recon- 
stituted by addition of PMA or I1:.-2. Moreover, CD4 T cells 
made very little or undetectable levels of most lymphokines 
in response to stimulation with conventional mitogens. Here 
we show kinetic results of stimulation with Con A plus PMA 
(Fig. 6), and we obtain a similar pattern with anti-CD3 plus 
or minus PMA, SEA,  or Con A  alone (Fig.  8).  The im- 
munodeficiency of the CD4 T cells in response to stimula- 
tion included lack of production of I1:2, I1:3, I1:.-4, I1:.-5, and 
IFN-% The results of I1:2, Ib3, and 11:4 were most striking 
because the CD4 population from normal mice made sub- 
stantial levels of those lymphokines when stimulated, while 
they made only low levels of IFN-3/and no detectable I1:5. 
In the experiments shown, purified CD4 T cells from both 
control and MAIDS animals were combined with fresh APC 
from normal animals so that the defect in MAIDS animals 
seen here is clearly in the CD4 T cell rather than in the APC 
population. A recent study by Gazzinelli et al. (36) suggested 
that whole spleen cells from MAIDS-infected animals secreted 
1I:4 and I1:10 in response to Con A from 4 to 12 wk postin- 
fection. Our studies differ from theirs in that we used iso- 
lated CD4 T cells supplemented  with APC from normal mice 
rather than whole spleen. It should also be mentioned that 
the levels of II:4 and I1:10 seen by Gazzinelli et al. (36) were 
rather modest. We have seen loss of 11:4 production consis- 
tently in more than five experiments. 
The changes in CD4 phenotype that accompany MAIDS 
suggest that the CD4 population has received signals that 
have driven all or at least most of the cells to an anergic state. 
We would suggest that the wholesale shift of CD4 cells to 
a phenotype characteristic  of memory or activated cells sup- 
ports the concept that most cells have participated in a re- 
sponse and have effectively differentiated to an anergic state. 
Recently, we have analyzed the phenotype of a population 
of CD4 T cells rendered anergic by treatment of mice with 
a bacterial  superantigen, SEA.  These anergic  CD4 T  cells 
have a phenotype indistinguishable from that of the MAIDS 
CD4 T  cells in this study (Swain,  S. L., D.  Hall,  and G. 
Huston, manuscript submitted for publication). Therefore, 
it seems likely that the phenotype described here for MAIDS 
CD4 T cells will be one generally representative  of that of 
T cells driven to the state of differentiation that corresponds 
to anergy. 
What kinds of mechanisms might lead to the polyclonal 
anergy seen in MAIDS? It has been suggested that vitally 
infected T cells may be influenced by viral genes and/or prod- 
ucts that could interfere with their function, and that if such 
T  cells proliferated they might be responsible  for the state 
of immunodeficiency (41). Several  considerations argue against 
such a model. First, CD4 T  cells have not been shown to 
be a major target of the virus, and so far virus has been de- 
tected primarily in macrophages (42) and in some B cells (26). 
Second, it would be expected that ff direct viral infection was 
required to suppress each T  cell, many uninfected CD4 T 
cells would continue to be responsive to stimulation, and the 
state of immunodeficiency  would not be so profound. Third, 
when cloned defective virus is introduced into mice using 
the ~-2 packaging system, so that virus cannot replicate and 
widely infect cells, it is nonetheless able to cause all or most 
manifestations of MAIDS (6,  7). 
A rapid and broadly polyclonal response of the kind ob- 
served in MAIDS would be most compatible with the exis- 
tence of a soluble, diffusible product capable of stimulating 
most or all CD4 T cells, rather than with a more limited event. 
It is for these reasons that some form of SAG-like mecha- 
nism is an attractive possibility.  The lack of V/3 selectivity, 
however, would suggest either that a novel, non-Vt3-selective 
SAG, mitogen, or active lymphokine is involved, or that a 
few initially infected or stimulated cells make such a broadly 
stimulating product. Although it can not be ruled out at 
the present time, there is no precedence for the latter possibility. 
Although the relationship of the murine BM5-induced dis- 
ease to human AIDS, induced by HIV, is unclear, they share 
several informative features. Both involve initial splenomegaly 
and  lymphadenopathy and  hypergammaglobulinemia. In 
AIDS there is convincing evidence that there is significant 
T cell immunodeficiency  before there is widespread infection 
of lymphocytes and selective CD4 depletion (e.g., reference 
43). Recently, it has been suggested that there is a selective 
loss of T cells bearing certain V~ and this has been taken 
as evidence of a possible HIV-associated SAG (44). It is likely 
that further experiments in the murine MAIDS model will 
reveal in more detail the mechanism of CD4 immunodeficiency 
caused by infection with the BM5 retrovirus, and that this 
could provide insights into other immunodeficiency syndromes 
as well as describe important aspects of viral-host interactions. 
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